Advate / Rixubis - direct healthcare professional communication (DHPC)

octocog alfa / Factor VIII Inhibitor Bypassing Activity / nonacog gamma
DHPCHuman

Swedish is available via eTranslation, the European Commission's machine translation service.

Translate to Swedish | Important information about machine translation

Om

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Dokument

Replacement BAXJECT II / BAXJECT II Hi-Flow Reconstitution Devices co-packaged with Advate/Feiba/Rixubis

Adopted

English (EN) (241.43 KB - PDF)

Först publicerad:
Visa

Key facts

Medicine name
  • Advate
  • Rixubis
Active substance
  • octocog alfa
  • Factor VIII Inhibitor Bypassing Activity
  • nonacog gamma
Regulatory outcome
Variation
DHPC type
Quality defect
Dissemination date

Share this page